Background Recent evidence suggests that, in coronary artery disease (CAD), myocardial blood flow (MBF) regulation is abnormal in regions supplied by apparently normal coronary arteries. However, the relation between this alteration and MBF response to increasing metabolic demand has not been fully elucidated.
Methods and Results MBF was assessed at baseline, during atrial pacing tachycardia, and after dipyridamole (0.56 mg/kg IV over 4 minutes) in 9 normal subjects and in 24 patients with ischemia on effort, no myocardial infarction, and isolated left anterior descending (n=19) or left circumflex (n=5) coronary artery stenosis (.50% diameter narrowing). Perfusion of both poststenotic (S) and normally supplied (N) areas was measured off therapy by positron emission tomography and [13Nlammonia.
Normal subjects and CAD patients showed similar rate-pressure products at baseline, during pacing, and after dipyridamole. In CAD patients, MBF was lower in S than in N territories at rest (0.68±0.14 versus 0.74±0.18 mL* min-. g-, respectively, T he issue of myocardial blood flow (MBF) regulation in patients with coronary artery disease (CAD) has long been a matter of controversy. In fact, although the majority of experimental and clinical literature has been focused on the striking effects of epicardial stenosis, several recent studies report an abnormal microvascular response to endothelium-mediated vasodilating agents,1 while others document a mild reduction in microvascular response to papaverine2 or dipyridamole. Unfortunately, despite its great clinical relevance, the overall effect of this microcirculatory abnormality on the myocardial oxygen demand-supply balance has not been clearly defined4-7; similarly, the MBF response to increased oxygen consumption has not been fully characterized in patients with CAD, mainly because of the limitations of the available methods (such as thermodilution or inert gas washout analysis) in the presence of perfusion heterogeneity. 8 The introduction of positron emission tomography for measuring regional MBF has helped to overcome many of the limitations of the previous methods. This technique provides a noninvasive reconstruction of absolute tracer concentrations in the myocardium and thereby absolute measurements of regional MBF.9 Moreover, because of the short half-life of radioisotopes, this technique allows repeated measurements under different conditions during the same session. In the present study, we applied this method to patients with singlevessel disease and without myocardial infarction, aiming to evaluate MBF response to increased metabolic demand (by atrial pacing) and its relation with maximal coronary vasodilation (elicited by dipyridamole) in myocardial regions supplied by both stenotic and nonstenotic coronary arteries. We used [13N]ammonia as a flow tracer, since its use has been validated in a broad range of flow conditions in both clinical and experimental studies.39~12
Methods

Study Population Patients With CAD
Twenty-four patients (mean age, 56±10 years) were included according to the following criteria: (1) history of angina pectoris; (2) evidence of ischemia either during exercise stress test (ST-segment depression, .1.5 mm) (n=7) or during dipyridamole echocardiography test according to the conventional criteria (n=5) or both (n= 12); (3) absence of clinical or ECG evidence of previous myocardial infarction; (4) angiographic documentation of single-vessel disease; and (5) absence of arterial hypertension and/or left ventricular hypertrophy (septal and posterior wall thickness .11 mm at twodimensional echocardiography).
Normal Subjects
Nine subjects (mean age, 47±6 years) with atypical chest pain were referred for coronary arteriography to exclude an organic cause of their symptoms. All had normal physical examination, resting ECG, chest radiograph, two-dimensional echocardiogram, and negative exercise stress test. All had normal coronary angiograms and left ventriculograms.
All patients and normal subjects agreed to participate in the study after being informed of the partially investigative nature of the protocol, which was approved by the local Ethics Committee on Human Studies.
Coronary Angiography and Left Ventriculography
Standard coronary angiography in multiple views was performed <2 weeks before the study. All angiograms were evaluated by two independent observers who identified the stenotic segments and scored control arteries as either smooth or irregular. Thereafter, all angiograms were evaluated by an automated edge detection system (Mipron; Kontron) providing the percent cross-sectional area reduction of coronary obstruction. Coronary arterial stenosis was located in the left anterior descending (19 patients; mean cross-sectional area reduction, 91±9%) and in the left circumflex coronary artery (5 patients; mean cross-sectional area reduction, 87±12%). Patients with >25% diameter reduction on the remaining coronary arteries were excluded. All patients had a dominant right coronary artery. Biplane left ventriculography was performed in all patients. The 300 right anterior projection was processed by a dedicated computer (Mipron; Kontron). The end-diastolic and end-systolic borders were manually outlined by visual inspection and contrast enhancement. Ectopic and postectopic beats were excluded. Six radial grids and areas were generated from the center of gravity of the ventricular silhouette to the endocardial borders. 13 Regional ejection fraction values obtained in each patient were compared with those obtained in 13 subjects with normal ventricular function and normal coronary arteries: values below 2 SD from the mean ejection fraction of the corresponding region of normal subjects were considered abnormal. Akinesis was defined by the absence of systolic excursion of the left ventricular wall. Mild to moderate dyssynergy was observed in 8 of 24 patients (33%) and was always located in the territory supplied by the stenotic artery (Table 1) .
Study Protocol
None of the patients were under 8-blocking therapy; calcium-channel blockers and long-acting nitrates were discontinued at least 5 plasma half-lives before the study. All min-* g-1 at rest, 0.92±0.29 mL-min'. -1 during pacing (P<.01 versus baseline), and 1.18±0.34 mLmin'l * g-' after dipyridamole (P<.01 versus both baseline and pacing) (Fig 1) . Flow values were significantly lower than those of both contralateral areas and normal subjects ( Table 2) . A significant inverse relation was observed between severity of epicardial stenosis (percent area reduction) and dipyridamole MBF (r= -.5, P<.03); by contrast, the degree of epicardial obstruction did not correlate with either baseline or pacing MBF (Fig 2) . Resting wall motion abnormalities in stenotic regions were shown by 8 of 24 patients (33%), while 16 showed normal regional function. Rate-pressure products and heart rates were similar in the two subgroups in all study conditions; no differences were observed in the severity of coronary artery stenosis (88±10% versus 89±10%, respectively, P=NS). Abnormal wall motion was not associated with lower MBF values in stenotic regions either at baseline (0.66±0.12 versus 0.69±0.15 mL * min'* g'-, respectively, P=NS) or during pacing tachycardia (0.87+ 0.25 versus 0.95±0.31 mL* min'* g-1, respectively, P=NS); however, a larger reduction in dipyridamole MBF (0.94±0.24 versus 1.30±0.33 mL * min' g-1, respectively, P<.02) and, consequently, in coronary reserve (dipyridamole/resting MBF) (1.44+0.33 versus 1.90+0.38, respectively, P<.01) was observed in patients with regional dysfunction (Fig 3) .
During pacing tachycardia, the occurrence of STsegment depression was not associated with a more severe reduction in MBF; however, the 15 patients with ischemic ECG abnormalities showed an incomplete utilization of actual vasodilating capability, while the remaining 9 patients showed a near maximal vasodilation: in fact, pacing MBF was significantly lower than maximal flow capacity, elicited by dipyridamole in the former (0.89+0.23 versus 1.22±0.36 mL. min-l g-', respectively, P<.05) but not in the latter (0.98±0.38 versus 1.14±0.32 mL min-1 g-', respectively, P=NS).
During pacing, rate-pressure products (17 854±2848 versus 16 757±2587 bpm * mm Hg, respectively, P=NS) and heart rates (125±14 versus 120±13 bpm, respectively, P=NS) were similar in both subgroups. An absolute decrease in MBF during increased oxygen consumption was observed in 4 of 24 patients, all of whom had ST-segment depression.
The 8 patients with and the 16 patients without ECG changes during dipyridamole infusion showed similar mL* min' g`after dipyridamole (P<.01 versus both baseline and pacing) (Fig 1) . Flow values were significantly lower than those in normal subjects under all conditions of the study protocol (Table 2) .
No differences in MBF values were observed between 10 vessels scored as irregular (<25% area reduction) and 14 scored as smooth in the three flow conditions.
Wall motion in areas supplied by normal coronary arteries was normal in all patients. Compared with the 16 patients with normal regional function, the 8 patients with resting wall motion abnormalities in poststenotic regions also showed a greater impairment in coronary reserve in these remote areas (1.89±0.50 versus 2.66±0.90, respectively, P<.05), although the differences in absolute MBF values did not achieve statistical significance (Fig 3) .
Patients In normal subjects, percent increase in rate-pressure product during pacing showed a significant correlation with the corresponding percent increase in MBF (r=.85, P<.01) (Fig 4) .
By contrast, in patients with single-vessel CAD, this correlation was completely absent, not only in myocardial regions supplied by stenotic coronary arteries (r=.08, P=NS) but also in remote contralateral areas (r=.04, P=NS) (Fig 4) . As (Fig 5) . ST-segment depression was observed in 9 of 13 and in 6 of 11 patients with and without perfusion defects, respectively (P=NS).
After dipyridamole, 18 of 24 patients (75%) showed a perfusion defect. With respect to those with homogeneous myocardial perfusion, these patients did not show a greater reduction in maximal flow in stenotic regions (1.16±0.38 versus 1.24±0.20 mL* minp1 * g-', respectively, P=NS); rather, they showed higher MBF values in contralateral areas (1.95±0.72 versus 1.22±0.28 mL min-14 g-1, P<.03) (Fig 5) . All 8 patients with ischemic ECG changes after dipyridamole showed perfusion defects. Discussion The major finding of the present study is that flow response to increased oxygen consumption is reduced in the whole myocardium of patients with single-vessel CAD. As a matter of fact, a reduced MBF response to pacing tachycardia and to dipyridamole infusion was observed not only in myocardial regions supplied by stenotic vessels but also in remote "control" regions supplied by nonstenotic arteries. Furthermore, the occurrence of ECG ischemia during increased oxygen consumption did not appear to be related to a greater reduction in maximal flow capacity in areas subtended by severely stenotic coronary arteries but rather to an incomplete utilization of coronary reserve during pacing in both stenotic and contralateral areas. Finally, a physiological relation between increase in rate-pressure product and increase in MBF was observed in normal subjects during pacing, while it was absent in both stenotic and contralateral regions of patients with single-vessel CAD.
Comparison With Previous Studies
The hydraulic effects of coronary stenosis have been elegantly defined both in animal models14 and in patients with CAD'5; however, it has not been fully established whether, in the latter, coronary atherosclerosis16 might affect the oxygen demand-supply balance by further factors besides epicardial obstruction. Using xenon washout technique, several authors4'17 have reported a global alteration in perfusion response to increased heart rate in patients with CAD, independently of the presence of stenosis and/or ischemia. Others5 have reported a normal behavior of MBF up to the onset of ST-segment depression and/or angina. A similar degree of discrepancy has been reported when great cardiac vein thermodilution is used.67 More recently, Nabel and colleagues18 observed, with Doppler catheter and quantitative angiography, a reduced flow response to pacing tachycardia in five vessels with "insignificant" atherosclerosis. Several factors may explain these disappointing discordancies. On one hand, the limitations of xenon and thermodilution techniques in measuring regional MBF under conditions of perfusion heterogeneity8 might have hampered the precise identification of stenotic and control beds. On the other hand, the high prevalence of patients with dilated cardiomyopathy,17 coronary atherosclerosis,6"17 and hypertension17'18 and of patients treated with p-blockers6 in both subjects with normal coronary arteries and patients with CAD might have hampered the precise definition of normal MBF response.
Positron emission tomography overcomes many of the limitations related to perfusion regionality, and when applied to patients with single-vessel disease, it allows an accurate identification of vascular territories.9 Moreover, because of its noninvasive nature, it can be easily applied in a truly normal control population. Using this technique, previous studies7'11 reported a difference in coronary reserve between collateral-dependent and control territories in patients with CAD" or between stenotic or remote regions of CAD patients and normal subjects.7 Very concordant findings have already been reported by our served in regions supplied by stenotic coronary arteries; however, MBF regulation was also abnormal in areas subtended by unobstructed vessels.
Microvascular Dysfunction in the "Control" Myocardium of Patients With CAD The major finding of the present study is a reduced flow response to atrial pacing in the myocardium supplied by angiographically normal coronary arteries of patients with CAD. This observation expands the physiological relevance of the impaired vasodilating capability in these "control" regions, which has already been reported in the literature2,3,7 and attributed to the endothelial dysfunction caused by atherosclerosis.2 In contrast to dipyridamole infusion, which directly dilates coronary microvessels19 without modifying metabolic demand, pacing tachycardia increases myocardial oxygen consumption, which, in turn, causes coronary vasodilation. Normal subjects and patients showed similar increases in rate-pressure product during pacing, thus ruling out differences in the main hemodynamic determinants of oxygen consumption. Therefore, the present data would suggest a role for microvascular dysfunction in the abnormal MBF response to pacing. In agreement with this hypothesis, several authors have observed a close correlation between the extent of endothelial dysfunction associated with atherosclerosis and the failure of coronary flow to increase during either cold pressor test2 or atrial pacing tachycardia. 18 However, a reduced flow response in the face of a normal increase in metabolic demand should have been associated with myocardial ischemic dysfunction: this phenomenon has never been described in myocardial regions supplied by normal vessels in patients with CAD. Thus, the microvascular dysfunction should be paralleled by unknown metabolic changes leading to lower flow requirements for a similar rate-pressure product. In this regard, Przyklenk and colleagues20 demonstrated that the occurrence of ischemia in one myocardial area also increases the endurance against coronary occlusion in the contralateral "virgin myocardium." Similarly, Uren and coworkers7 observed a reduced flow response to pacing tachycardia, in regions remote from coronary stenosis, associated with an abnormally increased glucose and alanine extraction. Unfortunately, the present study does not assess whether abnormal MBF behavior is the cause or the effect of an altered metabolism; however, it demonstrates that, whatever the mechanism, coronary atherosclerosis is associated with abnormalities of coronary microcirculation other than the effects of epicardial stenosis.
Flow Regulation in Dyssynergic Myocardium
Baseline wall motion abnormalities were observed in 8 of 24 This study provides insight into the pathophysiology of MBF regulation in CAD. However, it is not possible from our data to say whether, besides the hydraulic effects of coronary stenosis, the flow abnormalities of CAD patients are caused by a global microvascular dysfunction, by the occurrence of regional myocardial ischemia, or by a primary myocardial alteration. Probably, the measurement of regional oxygen consumption, which is now feasible with ["C]acetate and positron emission tomography,11 might have provided a more detailed understanding of the mechanism underlying this phenomenon. Unfortunately, this possibility was not present in our laboratory at the moment of study planning.
Because of the limited spatial resolution of positron emission tomography, transmural differences in regional MBF could not be investigated in the present study. Actually, this point might be of crucial relevance in the areas supplied by the stenotic coronary artery,36 in which the driving pressure is markedly affected by the pressure gradient caused by the stenosis. However, in the regions remote from the stenosis, an abnormal transmural distribution of flow would also imply the presence of a microvascular dysfunction as hypothesized on the basis of these data.
The apparent reduction in vasodilating capability in "control" regions might have been caused by the hemodynamic sequelae of ischemia. However, MBF values were markedly abnormal regardless of the presence of ST-segment depression during either pacing tachycardia or dipyridamole infusion, suggesting that the ischemic dysfunction cannot be considered to be totally responsible for flow impairment alone.
Caffeine and theophylline derivatives were withheld for at least 12 hours. Although significant levels of these compounds might have been present in the vascular compartment at this time, no patient was under treatment with these drugs, and therefore the very small residual concentration due to dietary intake should not induce a marked limitation of the effects of dipyridamole. Moreover, this limitation should also affect results obtained in normal subjects.
The factor used in correcting for variable ammonia extraction was derived from experiments in dogs,10 which may have led to some degree of uncertainty. However, any possible underestimation of MBF at high flow rates would imply an underestimation of the actual impairment of coronary reserve in CAD patients as a result of the relatively greater underrating of maximal flow in normal subjects.
Conclusions
The data of the present study demonstrate that vasodilating capability as well as the relation between rate-pressure product and MBF is altered in the whole myocardium of patients with single-vessel CAD. This alteration might occur at any point in the chain linking myocardial oxygen demand to MBF (ie, from the myocardial to the vascular cells).
These findings need further confirmation by similar or different methods able to provide absolute quantitative measurements of regional MBF; however, they add to the recently growing evidence that coronary atherosclerosis affects MBF regulation by mechanisms more complex than the simple epicardial artery obstruction.37 The impact of these observations is such as to modify our current understanding of the pathophysiology of coronary circulation in CAD. The proper use of positron emission tomography, in this field, allows the detection of phenomena that are absent in the experimental situation. These phenomena are characteristic of human cardiac disorders and are barely detectable by other clinical diagnostic tools.
